Evidence map›Paper›PMID 39261308›Full record

ArticleArchives of toxicology2024

Methodological steps forward in toxicological in vitro screening of mineral wools in primary rat alveolar macrophages and normal rat mesothelial NRM2 cells.

Christina Ziemann, Florian Schulz, Christoph Koch, Mette Solvang, Annette Bitsch

Abstract read
In one paragraph

Article in Archives of toxicology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christina ZiemannFraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs Str. 1, 30625, Hannover, Germany. christina.ziemann@item.fraunhofer.de.ORCID 0000-0002-3238-5385
Florian SchulzFraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs Str. 1, 30625, Hannover, Germany.ORCID 0009-0001-6956-8679
Christoph KochTechnical and Environmental Chemistry, Ernst-Abbe-University of Applied Sciences, Carl-Zeiss-Promenade 2, 07745, Jena, Germany.ORCID 0000-0002-7882-0784
Mette SolvangROCKWOOL A/S, Group Research and Development, Hovedgaden 584, 2640, Hedehusene, Denmark.ORCID 0009-0000-8060-4274
Annette BitschFraunhofer Institute for Toxicology and Experimental Medicine ITEM, Nikolai-Fuchs Str. 1, 30625, Hannover, Germany.ORCID 0000-0003-1539-2871

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Man-made vitreous fibers (MMVF) comprise diverse materials for thermal and acoustic insulation, including stone wool. Depending on dimension, durability, and dose, MMVF might induce adverse health effects. Therefore, early predictive in vitro (geno)toxicity screening of new MMVF is highly desired to ensure safety for exposed workers and consumers. Here, we investigated, as a starting point, critical in vitro screening determinants and pitfalls using primary rat alveolar macrophages (AM) and normal rat mesothelial cells (NRM2). A stone wool fiber (RIF56008) served as an exemplary MMVF (fibrous vs. ground to estimate impact of fiber shape) and long amosite (asbestos) as insoluble fiber reference. Materials were comprehensively characterized, and in vivo-relevant in vitro concentrations defined, based on different approaches (low to supposed overload: 0.5, 5 and 50 µg/cm

Indexed as

Macrophages, AlveolarMineral FibersAnimalsAsbestos, AmositeCell LineCells, CulturedDNA DamageDose-Response Relationship, DrugEpithelial CellsMaleRatsRats, WistarToxicity TestsAsbestos, AmositeMineral FibersCytotoxicityGenotoxicityIn vitroMineral woolsRat alveolar macrophagesRat mesothelial cells

Identifiers

PMID39261308
PMCPMC11496320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.